Fulcrum therapeutics to participate in upcoming investor conferences

Cambridge, mass., nov. 13, 2020 (globe newswire) -- fulcrum therapeutics, inc.  (nasdaq: fulc), a clinical-stage biopharmaceutical company focused on improving the lives of patients with genetically defined rare diseases, today announced that management will participate in the following virtual investor conferences:
FULC Ratings Summary
FULC Quant Ranking